|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/37 | (2006.01) |
| A61K 31/573 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3709996 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18724892.7 |
| Date of filing the European patent application | 2018-05-16 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation | 2024-06-25 |
| (86) | Number | PCT/EP2018/062805 |
| Date | 2018-05-16 |
| (87) | Number | WO 2019/096449 |
| Date | 2019-05-23 |
| (30) | Number | Date | Country code |
| PCT/EP2017/079506 | 2017-11-16 | WO |
| (72) |
BANERJI, Udai , GB
|
| (73) |
The Institute of Cancer Research: Royal Cancer
Hospital ,
123 Old Brompton Road, London SW7 3RP,
GB
The Royal Marsden NHS Foundation Trust , Fulham Road, London SW3 6JJ, GB |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kumarino darinys, skirtas ląstelių proliferacijos sutrikimo terapijai arba profilaktikai |
| COUMARIN DERIVATIVE FOR THERAPY OR PROPHYLAXIS OF A DISORDER OF CELL PROLIFERATION |
| Payment date | Validity (years) | Amount | |
| 2025-04-28 | 8 | 185.00 EUR |
| 2026-05-16 |